Abstract
Acute eosinophilia-myalgia syndrome (EMS) due to contaminated L-tryptophan (LT) exposure is an inflammatory microangiopathy of the dermis, fascia, and muscle. Select individuals evolve from acute EMS to have persistence of myalgia, fatigue, cramps, and skin changes for years. Many develop memory dysfunction and confusion. The objective of this study is to delineate the pathology in individuals with chronic EMS. Seventeen patients with ongoing symptoms representing chronic EMS are studied by skin, fascia, and muscle biopsies four to five years after exposure to contaminated LT and initial onset of EMS. All have microvascular disease. Most have lymphocytic inflammatory infiltrates. Several have dermal sclerosis. The findings indicate that persistent microvascular disease is present in chronic EMS. The pathologic changes are similar to those of acute EMS but with notable differences. Tissue eosinophil infiltration is rare in the chronic state as compared to acute EMS. The degree of inflammation in chronic EMS is markedly reduced compared to acute EMS. The persistence of endothelial pathology indicates continuing microvascular dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Emslie-Smith A.M, Engel A. G., Duffy J., et al., 1991, Eosinophilia myalgia syndrome, I:immunocytochemical evidence for a T-cell-mediated immune effector response. Ann Neurol29: 524.
Eosinophilia-myalgia syndrome and L-tryptophan-containing products — New Mexico, Minnesota, Oregon, and New York. MMWR38: 785–88 (1989).
Glickstein S.L., Gertner E., Smith S.A., et al, 1990, Eosinophilia-myalgia syndrome associated with L-tryptophan. J Rheumatol17: 1534.
Hertzman P.A., Blevins W.L., Mayer J., et al, 1990, Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N End J Med322: 869.
Kaufman L.D., 1993, Eosinophilia-myalgia syndrome: morbidity and mortality [editorial]. J Rheumatol20: 1644.
Kaufman L.D., 1994, The evolving spectrum of eosinophilia myalgia syndrome. Rheum Dis Clin North Amer20: 973.
Silver R.M., Heyes M.P., Maize J.C., et al, 1990, Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Eng J Med322: 874.
Smith S.A., 1992 Pathology of eosinophilia-myalgia syndrome, in: “Advances in Tryptophan Research,” I. Ishiguro, R. Kido, T. Nagatsu, et al, eds., Fujita Health University Press, Toyoake, p. 9375–78.
Smith S.A., 1994, Pathology of the microangiopathy and immunohistochemistry of the inflammatory infiltrate in eosinophilia-myalgia syndrome, in: “L-Tryptophan Current Prospects in Medicine and Drug Safety,” W. Kochen, H. Steinhart, eds., Walter de Gruyter, Berlin 223–33
Smith S.A., Roelofs R.I., Gertner E., 1990 Microangiopathy in the eosinophilia-myalgia syndrome. J Rheumatol17: 1544.
Swygert L.A., Back E.E., Auerbach S.B., et al., 1993, Eosinophilia-myalgia syndrome: mortality data from the U.S. national surveillance system. J Rheumatol20: 1711.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Smith, S.A. (1996). Persistent Microvasculopathy In Chronic Eosinophilia-Myalgia Syndrome. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_55
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0381-7_55
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8026-9
Online ISBN: 978-1-4613-0381-7
eBook Packages: Springer Book Archive